196 related articles for article (PubMed ID: 33134809)
1. Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study.
Mori S; Arima N; Ito M; Ueki Y; Abe Y; Aoyagi K; Fujiyama S
Rheumatol Adv Pract; 2020; 4(2):rkaa020. PubMed ID: 33134809
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
[TBL] [Abstract][Full Text] [Related]
4. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate hepatotoxicity in patients with rheumatoid arthritis.
Sotoudehmanesh R; Anvari B; Akhlaghi M; Shahraeeni S; Kolahdoozan S
Middle East J Dig Dis; 2010 Sep; 2(2):104-9. PubMed ID: 25197521
[TBL] [Abstract][Full Text] [Related]
7. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
[TBL] [Abstract][Full Text] [Related]
8. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
Langman G; Hall PM; Todd G
J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-associated nonalcoholic fatty liver disease with transaminitis in rheumatoid arthritis.
Sakthiswary R; Chan GY; Koh ET; Leong KP; Thong BY
ScientificWorldJournal; 2014; 2014():823763. PubMed ID: 24971392
[TBL] [Abstract][Full Text] [Related]
10. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate Hepatotoxicity in Rheumatoid Arthritis: An Analysis of the Physicians' Policy.
Anvari B
Curr Rheumatol Rev; 2020; 16(1):67-73. PubMed ID: 31244428
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms.
Ezhilarasan D
Toxicology; 2021 Jun; 458():152840. PubMed ID: 34175381
[TBL] [Abstract][Full Text] [Related]
13. Validation of the fibrosis-4 (FIB-4) index in the diagnosis of liver disease of rheumatoid arthritis patients treated with methotrexate.
Miyata M; Kuroda M; Unakami M; Tasaki K; Migita K; Ohira H
Mod Rheumatol; 2019 Nov; 29(6):936-942. PubMed ID: 30379089
[No Abstract] [Full Text] [Related]
14. Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
Mori S; Yoshitama T; Abe Y; Hidaka T; Hirakata N; Aoyagi K; Ueki Y
Rheumatology (Oxford); 2019 Jul; 58(7):1274-1284. PubMed ID: 30793749
[TBL] [Abstract][Full Text] [Related]
15. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature.
Visser K; van der Heijde DM
Clin Exp Rheumatol; 2009; 27(6):1017-25. PubMed ID: 20149325
[TBL] [Abstract][Full Text] [Related]
16. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis.
Osuga T; Ikura Y; Kadota C; Hirano S; Iwai Y; Hayakumo T
Int J Clin Exp Pathol; 2015; 8(2):1961-6. PubMed ID: 25973089
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
[TBL] [Abstract][Full Text] [Related]
18. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
Humphreys JH; Warner A; Costello R; Lunt M; Verstappen SMM; Dixon WG
Ann Rheum Dis; 2017 Sep; 76(9):1509-1514. PubMed ID: 28341765
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
[TBL] [Abstract][Full Text] [Related]
20. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients.
Brick JE; Moreland LW; Al-Kawas F; Chang WW; Layne RD; DiBartolomeo AG
Semin Arthritis Rheum; 1989 Aug; 19(1):31-44. PubMed ID: 2772658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
